dimyristoylphosphatidylglycerol has been researched along with andrographolide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahiwale, RJ; Chellampillai, B; Pawar, AP | 1 |
1 other study(ies) available for dimyristoylphosphatidylglycerol and andrographolide
| Article | Year |
|---|---|
Investigation of 1,2-Dimyristoyl-sn-Glycero-3-Phosphoglycerol-Sodium (DMPG-Na) Lipid with Various Metal Cations in Nanocochleate Preformulation: Application for Andrographolide Oral Delivery in Cancer Therapy.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Calorimetry, Differential Scanning; Cations; Diterpenes; Doxorubicin; Drug Carriers; Female; Humans; Nanoparticles; Neoplasms; Particle Size; Phosphatidylglycerols; Rats; Rats, Wistar; Sodium; Solubility; Tissue Distribution | 2020 |